55
https://pubmed.ncbi.nlm.nih.gov/38117448
Rubiscolin-6 analogs have neuroprotective and anti-inflammatory effects in in vitro models, potentially through an antioxidation mechanism and activation of the PI3-K/AKT/mTOR pathway.